News
News Center
2023-12-11
Fitness superstar Chris: Undergoing stem cell therapy as kidney issues raise concerns.
Recently, foreign media reported that international bodybuilding superstar Chris is undergoing stem-cell therapy, aimed at preventing potential future health issues.
+
2023-12-11
On December 3, 2023, Jiuzhitang Maker’s preclinical pharmacodynamic study titled "Intravenous transplantation of bone marrow-derived mesenchymal stem cells improved behavioral deficits and altered fecal microbiota composition of BTBR mice," which explores the use of human bone marrow mesenchymal stem cells (hBMMSC) to treat autism, was officially accepted and published in the internationally renowned academic journal *Life Sciences*.
+
2023-12-11
Jiuzhitang Maker named to Huayi List's "Top 10 Most Promising Stem Cell Companies" list
On December 7-8, 2023, the highly anticipated "Huayi List · 2023 Cell and Gene Therapy Industry Visionary Ranking," jointly launched by YiYun Technology, Pinhe Medical, and BioValley, was officially unveiled. Jiuzhitang Maker was named among the "Top 10 Most Promising Stem Cell Companies" on the Huayi List.
+
2023-11-23
Jiuzhitang Maker's participation in establishing the Hunan Provincial Key Laboratory is a strong recognition of the company's deep expertise and groundbreaking research achievements in stem-cell-based pharmaceutical quality. It also highlights the critical R&D direction for stem-cell products in the pharmaceutical field. Moving forward, Jiuzhitang Maker will fully leverage its cutting-edge stem-cell research capabilities to drive innovation and accelerate clinical translation of stem-cell technologies, continuously fueling the high-quality development of the Hunan Provincial Key Laboratory.
+
2023-11-21
“Standards provide a valuable reference for both research and application, serving as a fundamental guarantee for industry development,” said Ji Weizhi, an academician of the Chinese Academy of Sciences and director of the Primate Translational Medicine Research Institute at Kunming University of Science and Technology. He added that currently, developing standards in the stem cell field still faces significant challenges. However, as research into stem cell theories and technologies continues to advance, he believes more innovative standards will emerge—while existing ones will be refined further—to better propel progress in this cutting-edge area.
+
2023-11-04
On November 1, 2023, the kickoff meeting for the clinical trial of human bone marrow mesenchymal stem cell injection therapy for a rare lung disease—autoimmune alveolar proteinosis (aPAP)—co-sponsored by Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. (hereafter referred to as "Jiuzhitang Maker") and the First Affiliated Hospital of Guangzhou Medical University (hereafter referred to as "Guangyi Yiyuan"), was successfully held. Academician Zhong Nanshan attended the entire event and provided guidance throughout the trial.
+
2023-10-10
Stem Cell Science Comic (8) | Stem Cells in the Treatment of Ischemic Stroke
Original science popularization article on stem cells!
+
2023-09-19
Stem Cell Science Comic (7) | Stem Cells for Treating Skin Photoaging
Original science popularization article on stem cells!
+
2023-08-15
Stem Cell Science Comic (6) | Stem Cells in COVID-19 Treatment
Original science popularization article on stem cells!
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy